Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors

Trial Profile

Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2011

At a glance

  • Drugs Laromustine (Primary)
  • Indications Brain cancer; Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Jun 2011 Last checked against ClinicalTrials.gov record.
    • 22 Feb 2008 Status change from in progress to completed.
    • 01 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top